Comparing two different doses of inotuzumab ozogamicin treatment in adult patients with acute lymphoblastic leukemia: a plain language summary of publication
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Özcan M.
- Cassaday R.D.
- Zarzycka E.
- Vandendries E.
- Zhang F.
- Chen Y.
- Nieto A.
- Demirkan F.
- Altuntas F.
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 1758-8340, 1758-8359
- Tipo:
- Review
- Páginas:
- -
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,488 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Therapeutic Advances in Medical Oncology SAGE PUBLICATIONS LTD
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- inotuzumab ozogamicin; acute lymphoblastic leukemia; adult; adverse drug reaction; controlled study; drug therapy; human; liver venoocclusive disease; low drug dose; major clinical study; open access; plain language summary; prevention; recommended drug dose; review; side effect; therapy; vein occlusion
Cita
Özcan M,Cassaday RD,Zarzycka E,Vandendries E,Zhang F,Chen Y,Nieto A,Demirkan F,Montesinos P,Altuntas F. Comparing two different doses of inotuzumab ozogamicin treatment in adult patients with acute lymphoblastic leukemia: a plain language summary of publication. Ther. Adv. Med. Oncol. 2025. 1717588359251370948. IF:4,100. (2).
Portal de investigación